These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 22103853)
1. PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases. Shenker BJ; Ali H; Boesze-Battaglia K Curr Pharm Des; 2011 Nov; 17(34):3815-22. PubMed ID: 22103853 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of mast cell degranulation by a chimeric toxin containing a novel phosphatidylinositol-3,4,5-triphosphate phosphatase. Shenker BJ; Boesze-Battaglia K; Zekavat A; Walker L; Besack D; Ali H Mol Immunol; 2010; 48(1-3):203-10. PubMed ID: 20863570 [TBL] [Abstract][Full Text] [Related]
3. Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate. Shenker BJ; Walker LP; Zekavat A; Boesze-Battaglia K Mol Oral Microbiol; 2016 Feb; 31(1):33-42. PubMed ID: 26299277 [TBL] [Abstract][Full Text] [Related]
4. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996 [TBL] [Abstract][Full Text] [Related]
5. Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation. Arthur GK; Cruse G Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054974 [TBL] [Abstract][Full Text] [Related]
6. The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Shenker BJ; Boesze-Battaglia K; Scuron MD; Walker LP; Zekavat A; Dlakić M Cell Microbiol; 2016 Feb; 18(2):223-43. PubMed ID: 26247396 [TBL] [Abstract][Full Text] [Related]
16. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE. Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196 [TBL] [Abstract][Full Text] [Related]
17. Rac and phosphatidylinositol 3-kinase regulate the protein kinase B in Fc epsilon RI signaling in RBL 2H3 mast cells. Djouder N; Schmidt G; Frings M; Cavalié A; Thelen M; Aktories K J Immunol; 2001 Feb; 166(3):1627-34. PubMed ID: 11160204 [TBL] [Abstract][Full Text] [Related]
18. Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release. Kuehn HS; Beaven MA; Ma HT; Kim MS; Metcalfe DD; Gilfillan AM Cell Signal; 2008 Apr; 20(4):625-36. PubMed ID: 18207701 [TBL] [Abstract][Full Text] [Related]
19. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Kepley CL Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210 [TBL] [Abstract][Full Text] [Related]
20. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells. MacNeil AJ; Yang YJ; Lin TJ J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]